Profile Previews

Get a glimpse into our company and investor data—powered by the PitchBook Platform

Navitas Assets (Cicletanine Business)

M&A STATUS
M&A LATEST DEAL TYPE
1 FINANCING ROUNDS
Description

Developer of hypertension drug. The company develops and produces drug, oral drug agents and treatments for pulmonary arterial hypertension.

Ownership Status
Acquired/Merged
Financing Status
Corporate Backed or Acquired
Primary Industry
Drug Discovery
Acquirer
Primary Office
  • United States

Navitas Assets (Cicletanine Business) Valuation and Funding

Deal Type Date Amount Post-Val Valuation/
EBITDA
Debt Status

This information is reserved for PitchBook Platform users. To explore Navitas Assets (Cicletanine Business)‘s full profile, request access.

Request full access to PitchBook

Navitas Assets (Cicletanine Business) Former Investors

Investor Name Investor Type Holding Participating Rounds Investor Since Board Seat Contact Info

This information is reserved for PitchBook Platform users. To explore Navitas Assets (Cicletanine Business)‘s full profile, request access.

Request full access to PitchBook